Effect of switching administration of alendronate after teriparatide for the prevention of BMD loss around the implant after total hip arthroplasty, 2-year follow-up: a randomized controlled trial

BACKGROUND: Stress shielding after total hip arthroplasty (THA) can induce bone mineral density (BMD) loss around the femoral implant. Several studies using drug have described methods to prevent BMD loss around implants following THA. Switching from teriparatide to alendronate was reported to incre...

Descripción completa

Detalles Bibliográficos
Autores principales: Morita, Akira, Kobayashi, Naomi, Choe, Hyonmin, Ike, Hiroyuki, Tezuka, Taro, Higashihira, Shota, Inaba, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966791/
https://www.ncbi.nlm.nih.gov/pubmed/31948455
http://dx.doi.org/10.1186/s13018-020-1547-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966791/
https://www.ncbi.nlm.nih.gov/pubmed/31948455
http://dx.doi.org/10.1186/s13018-020-1547-5

Ejemplares similares